Both in Biotechnology
Passage Bio vs Intensity Therapeutics
Over the past year PASG returned −48.9% and INTS returned −79.0%; their daily moves had a correlation of 0.10.
PASG −48.9% INTS −79.0%Growth of $1, one year, split-adjusted
| Metric | PASG | INTS |
|---|---|---|
| Price | $3.40 | $2.81 |
| Market cap | $10.9M | $9.2M |
| Today | −3.28% | −19.71% |
| 1 month | −11.9% | −26.1% |
| 6 months | −16.8% | −45.0% |
| Year to date | −71.2% | −72.6% |
| 1 year | −48.9% | −79.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $24.2M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 77.4% | 76.5% |
| Short % of float | 2.4% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).